By Craig Erlam European stocks are making steady gains on Monday, recovering a small portion of last week’s heavy losses as economic concerns mounted. There’s been a shift in the market mindset
The European Medicines Agency (EMA) has started a rolling review for a Spikevax (Moderna) vaccine adapted to provide better protection against specific variants of SARS-CoV-2. The Ministry of Health said the review
Interior Minister Nicos Nouris and the International Organisation for Migration’s Regional Director, Ola Henrikson, discussed ways to enhance and increase financial cooperation between the two parties to return irregular migrants. During his first
Breakaway Turkish Cypriots are responsible for stemming migrant arrivals, a senior European Union official said, as the number of asylum-seekers the Republic receives soars. European Commission Vice President Margaritis Schinas said that
By Jeffrey Halley The “R” word is being used more and more as recessionary winds start blowing loudly through economic data and the price actions across the asset class spectrum. On Friday,
You know the world is in turmoil with the war in Europe, tempers frayed in the Aegean, the cost of living is no longer sufferable, and climate change will fry us all.
By Craig Erlam I think we all earned a weekend break in the sun after a quite extraordinary week in the markets that saw plenty of central bank action, even from those
Greek Prime Minister Kyriakos Mitsotakis said Friday he preferred diplomacy over ratchet rhetoric with Turkey over disagreements in the Aegean Sea, where the two are at loggerheads over territory and airspace. Mitsotakis
The European Medicines Agency (EMA) has started a rolling review for a version of Comirnaty adapted to provide better protection against a specific variant or variants of SARS-CoV-2, the virus that causes COVID-19.
By Jeffrey Halley The post-FOMC rally ran equities out of steam within 24 hours with Wall Street plummeting overnight once again. Even the most ardent FOMO gnome had a conviction crisis as
